BioAge Labs, Inc. (BIOA)
5.78
-0.16
(-2.69%)
USD |
NASDAQ |
Oct 13, 09:38
BioAge Labs Net Income (TTM) : -94.46M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -94.46M |
| March 31, 2026 | -89.93M |
| December 31, 2025 | -80.60M |
| September 30, 2025 | -75.79M |
| June 30, 2025 | -79.03M |
| March 31, 2025 | -71.04M |
| Date | Value |
|---|---|
| December 31, 2024 | -71.11M |
| September 30, 2024 | -70.94M |
| June 30, 2024 | -62.16M |
| March 31, 2024 | -65.76M |
| December 31, 2023 | -63.85M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Neumora Therapeutics, Inc. | -212.74M |
| Alumis, Inc. | -438.96M |
| ANI Pharmaceuticals, Inc. | 99.95M |
| Corcept Therapeutics, Inc. | 54.20M |
| Veru, Inc. | -14.11M |